Best Peptides for Motility Disorders

Motility disorders involve impaired coordinated muscle contractions in the digestive tract, preventing normal movement of food from the esophagus through the intestines. Research into peptide therapeutics for these conditions focuses on agents that may enhance smooth muscle contractility and neuronal signaling in the GI tract. While peptides like motilin receptor agonists have been investigated for their potential to stimulate gastric contractions, current research remains in preclinical and early clinical stages with limited established protocols.

Motility-targeted peptide research typically explores timing around meals to optimize effects on digestive function, though standardized dosing protocols remain under investigation. Researchers generally consider both acute and chronic dosing schedules depending on the specific peptide mechanism and study objectives.